HIGH-DOSE CHEMOTHERAPY IMPAIRS COGNITIVE-FUNCTIONING MORE THAN STANDARD-DOSE CHEMOTHERAPY IN WOMEN RECEIVING ADJUVANT TREATMENT FOR HIGHRISK BREAST-CANCER
Fsam. Vandam et al., HIGH-DOSE CHEMOTHERAPY IMPAIRS COGNITIVE-FUNCTIONING MORE THAN STANDARD-DOSE CHEMOTHERAPY IN WOMEN RECEIVING ADJUVANT TREATMENT FOR HIGHRISK BREAST-CANCER, Quality of life research, 6(7-8), 1997, pp. 398-398